U.S. cannabis firm PharmaCann plans IPO as New York weed legalization lifts demand -sources
PharmaCann, one of the 10 original cannabis licensees in New York, has confidentially filed for an initial public offering that could value it at well over $1 billion, sources familiar with the matter told Reuters.
